GlassScriptPhysician profile
Michael Peter Mariorenzi
NPI 1093701948
$3,967.28
in general payments reported to CMS, 2019-2025
25 companies · $210 in 2025
The $210 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,328 · 2020: $586 · 2021: $797 · 2022: $416 · 2023: $602 · 2024: $28.27 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $840.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $840.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,218.25 | 2019-2025 | Rio, Pangea |
| Amgen INC. | $802.25 | 2019-2023 | Enbrel, Tavneos |
| Pacira Therapeutics, INC. | $334.68 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $317.47 | 2021-2024 | Rosa, Persona |
| Abbvie INC. | $144.86 | 2019-2023 | |
| Horizon Therapeutics Plc | $124.99 | 2021 | |
| Medical Device Business Services, INC. | $116.05 | 2025 | Velys |
| Smith+Nephew, INC. | $113.56 | 2019-2021 | |
| Celgene Corporation | $106.24 | 2019 | |
| Mallinckrodt Hospital Products INC. | $83.20 | 2023 | Acthar |
| Novartis Pharmaceuticals Corporation | $73.82 | 2019 | |
| Bioventus LLC | $66.97 | 2020-2021 | |
| Pfizer INC. | $61.26 | 2020-2023 | |
| Orthofix Medical, INC. | $58.11 | 2022 | |
| Ferring Pharmaceuticals INC. | $54.89 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $50.40 | 2019-2023 | Tremfya |
| Endo Pharmaceuticals INC. | $50.08 | 2020-2023 | Xiaflex |
| Zyla Life Sciences, INC. | $42.03 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $36.90 | 2022 | |
| Antares Pharma, INC. | $31.58 | 2020-2021 | |
| Vericel Corporation | $23.49 | 2023 | Maci |
| Baudax Bio INC. | $16.19 | 2020 | |
| Ethicon US, LLC | $15.07 | 2020 | |
| Avanos Medical | $13.17 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $11.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mariorenzi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.